EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivo

Despite a well-established role for the epidermal growth factor receptor (EGFR) in tumorigenesis, EGFR activities and endocytosis in tumors in vivo have not been studied. We labeled endogenous EGFR with GFP by genome-editing of human oral squamous cell carcinoma cells, which were used to examine EGF...

Full description

Bibliographic Details
Main Authors: Itziar Pinilla-Macua, Alexandre Grassart, Umamaheswar Duvvuri, Simon C Watkins, Alexander Sorkin
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2017-12-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/31993
_version_ 1828166466282717184
author Itziar Pinilla-Macua
Alexandre Grassart
Umamaheswar Duvvuri
Simon C Watkins
Alexander Sorkin
author_facet Itziar Pinilla-Macua
Alexandre Grassart
Umamaheswar Duvvuri
Simon C Watkins
Alexander Sorkin
author_sort Itziar Pinilla-Macua
collection DOAJ
description Despite a well-established role for the epidermal growth factor receptor (EGFR) in tumorigenesis, EGFR activities and endocytosis in tumors in vivo have not been studied. We labeled endogenous EGFR with GFP by genome-editing of human oral squamous cell carcinoma cells, which were used to examine EGFR-GFP behavior in mouse tumor xenografts in vivo. Intravital multiphoton imaging, confocal imaging of cryosections and biochemical analysis revealed that localization and trafficking patterns, as well as levels of phosphorylation and ubiquitylation of EGFR in tumors in vivo closely resemble patterns and levels observed in the same cells treated with 20–200 pM EGF in vitro. Consistent with the prediction of low ligand concentrations in tumors, EGFR endocytosis was kinase-dependent and blocked by inhibitors of clathrin-mediated internalization; and EGFR activity was insensitive to Cbl overexpression. Collectively, our data suggest that a small pool of active EGFRs is sufficient to drive tumorigenesis by signaling primarily through the Ras-MAPK pathway.
first_indexed 2024-04-12T02:01:50Z
format Article
id doaj.art-e5bff5934d244e2b87f6a671a0cbc5cc
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-04-12T02:01:50Z
publishDate 2017-12-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-e5bff5934d244e2b87f6a671a0cbc5cc2022-12-22T03:52:39ZengeLife Sciences Publications LtdeLife2050-084X2017-12-01610.7554/eLife.31993EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivoItziar Pinilla-Macua0Alexandre Grassart1Umamaheswar Duvvuri2Simon C Watkins3Alexander Sorkin4https://orcid.org/0000-0002-4446-1920Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, United StatesDepartment of Molecular Microbial Pathogenesis, Institute Pasteur, Paris, FranceDepartment of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, United StatesDepartment of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, United StatesDepartment of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, United StatesDespite a well-established role for the epidermal growth factor receptor (EGFR) in tumorigenesis, EGFR activities and endocytosis in tumors in vivo have not been studied. We labeled endogenous EGFR with GFP by genome-editing of human oral squamous cell carcinoma cells, which were used to examine EGFR-GFP behavior in mouse tumor xenografts in vivo. Intravital multiphoton imaging, confocal imaging of cryosections and biochemical analysis revealed that localization and trafficking patterns, as well as levels of phosphorylation and ubiquitylation of EGFR in tumors in vivo closely resemble patterns and levels observed in the same cells treated with 20–200 pM EGF in vitro. Consistent with the prediction of low ligand concentrations in tumors, EGFR endocytosis was kinase-dependent and blocked by inhibitors of clathrin-mediated internalization; and EGFR activity was insensitive to Cbl overexpression. Collectively, our data suggest that a small pool of active EGFRs is sufficient to drive tumorigenesis by signaling primarily through the Ras-MAPK pathway.https://elifesciences.org/articles/31993EGF receptortumourendocytosis
spellingShingle Itziar Pinilla-Macua
Alexandre Grassart
Umamaheswar Duvvuri
Simon C Watkins
Alexander Sorkin
EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivo
eLife
EGF receptor
tumour
endocytosis
title EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivo
title_full EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivo
title_fullStr EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivo
title_full_unstemmed EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivo
title_short EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivo
title_sort egf receptor signaling phosphorylation ubiquitylation and endocytosis in tumors in vivo
topic EGF receptor
tumour
endocytosis
url https://elifesciences.org/articles/31993
work_keys_str_mv AT itziarpinillamacua egfreceptorsignalingphosphorylationubiquitylationandendocytosisintumorsinvivo
AT alexandregrassart egfreceptorsignalingphosphorylationubiquitylationandendocytosisintumorsinvivo
AT umamaheswarduvvuri egfreceptorsignalingphosphorylationubiquitylationandendocytosisintumorsinvivo
AT simoncwatkins egfreceptorsignalingphosphorylationubiquitylationandendocytosisintumorsinvivo
AT alexandersorkin egfreceptorsignalingphosphorylationubiquitylationandendocytosisintumorsinvivo